Contacts: Anthony Viscogliosi, Small Bone Innovations, Inc. (212)
583-9700 ext. 100
Nick Kilsby, Creative Partners, (203) 750-9212, Cell: 203-829-6400
BONE INNOVATIONS, INC. SOLIDIFIES KEY BUSINESS FUNCTIONS WITH MANAGEMENT
YORK NY, February 9, 2007 - Small
Bone Innovations, Inc. (SBi), a single-source provider of innovation,
products, technology and education for the small bone & joint sector
of the orthopedic industry, has strengthened major areas of its operation,
as key members of its world-class management team have been promoted
to new roles.
Senior Vice President, International Sales,
Managing Director, SBi International, SAS
Martin has been promoted to the position of Senior Vice President,
International Sales, where he will focus his full attention and
energy on managing all SBi sales outside of the US. Jean-Jacques
will also retain his position as Managing Director, SBi International,
SAS. He joined the company in March 2005.
Before joining SBi, Mr. Martin was the Director/President of Fixano,
SAS, a privately-held French orthopedic company based near Lyon, France.
Mr. Martin founded Fixano, SAS in 1987 with an external fixation product
line of ring fixators and in-house manufacturing. During Mr. Martin’s
18 years of experience with Fixano, he was responsible in developing,
manufacturing, and marketing technologies in orthopedics, trauma, and
Mr. Martin has more than 20 years of experience in orthopedics and
attended Universite in Lyon, France.
Senior Vice President, Worldwide Marketing, Reimbursement &
Frederick, Vice President, Worldwide Marketing, has been promoted
to the position of Senior Vice President, Worldwide Marketing,
Reimbursement & National Accounts. In addition to leading the
company’s marketing & public relations efforts, managing
the Product Portfolio, market development, product introduction,
product packaging and corporate image, he will now also be responsible
for SBi’s global reimbursement issues and national accounts.
Chris joined SBi in November 2005.
Before joining SBi, Mr. Frederick spent 16 years with Johnson &
Johnson in the Medical Device Division at Ethicon Endo-surgery and
Cordis Endovascular. He was Vice President of Marketing for Cordis
Endovascular, a unit of Johnson & Johnson, and led an interdependent
team integrating Market Development, US Marketing, Global Marketing
and Marketing Communications. Prior to Cordis, Mr. Frederick held senior
management-level positions at Ethicon Endo-Surgery in Ohio and in the
Mr. Frederick has more than 20 years experience in Medical Device Marketing
and Sales, and holds a BS in Business Administration and Marketing
from Bloomsburg University.
M. Pachuda, D.P.M.
Vice President, Worldwide Medical Education & Clinical Studies
Nicholas M. Pachuda, Vice President, Medical Education, has been
promoted to the position of Vice President, Worldwide Medical Education & Clinical
Studies. He now leads SBi’s company-wide medical education
efforts around the globe, while also creating a structured clinical
studies strategy that addresses SBi’s needs and serves to
complement and advance all levels of our operations.
Prior to joining SBi in June of 2005, Dr. Pachuda was a Small Joint
Product Manager for Arthrex, Inc., a company dedicated to the development
of innovative arthroscopy products for Sports Medicine. Before Arthrex,
Dr. Pachuda owned and managed a private foot and ankle surgical practice,
which was among the top income grossing private practices in the US.
Dr. Pachuda was also Board Certified in foot, rearfoot, and ankle reconstructive
surgery as well as Podiatric Orthopedics.
Dr. Pachuda has more than 19 years experience in small joint surgery
and holds a BS in Biology from the University of Pittsburgh and a DPM
from Pennsylvania College of Podiatric Medicine. He completed his surgical
training at the University of Medicine and Dentistry of NJ, followed
by an Orthopedic Trauma Fellowship in Germany. Dr. Pachuda was also
part of the AO (Arbeitsgemeinschaft für Osteosynthesefragen) International
teaching faculty, and has authored several publications and textbooks.
Vice President, Worldwide Product Development & Technology
Loring has been promoted to the popment,
where he will add the natural, synergistic complement of Technology
Development to his duties in Product Development.
Tom came to SBi from Osteotech, Inc. where he was Senior Director of Product
Development and Orthobiologics. In this role, Mr. Loring led all research and
development efforts on bone/polymer composite biomaterials.
Prior to working at Osteotech, Inc., Mr. Loring was employed by Stryker Orthopaedics
for eleven years where he held senior management positions in Product and Business
Development. While in the Business Development role at Stryker, he put together
a plan to create a dedicated business unit focused on the small bone market.
Mr. Loring received his BS in Management/Industrial Engineering from Worcester
Polytechnic Institute and his MBA from Dartmouth College, The Amos Tuck School
of Business Administration.
Additionally, Small Bone Innovations has announced
the following Management promotions:
Thomas Mezzio has been promoted to the position of Director of Investor Relations,
and adds this role to his current position as Chief of Staff. Tom is now responsible
for SBi’s investor relations, investor meetings and communications, in
addition to his existing Company and Board of Director relations duties.
Matt Tilley has been promoted to the position of North American Western Regional
Sales Manager. Matt now oversees the entire Western region, including the Los
Angeles area, where he had served SBi as a Direct Rep.
Fred Bandel has been promoted to the position of International Upper Limb Project
Manager, a position focused on technical training &
education, surgical consulting and sales. This sales-based marketing
role and will work closely in conjunction with surgeons outside the
U.S. Fred will be based out of SBi’s Bourg-en-Bresse, France
office.sition of VP, Worldwide Product
Development & Technology Develo
SBi has also announced three new recent additions to their
Bruce Berman has been hired as North American Eastern Regional Sales
Jacques Nicolini has been hired as a new Direct Sales Rep, covering
France. Jacques was formerly with Mitek Surgical Products, a Johnson
& Johnson Company.
Françoise Saintilan has been hired as a new Direct Sales Rep,
SBi Chairman and CEO Anthony G. Viscogliosi commented on the management
team enhancements, saying, “I take great pride in having assembled
the most talented and dedicated management team I have ever worked
with, in my more than 20 years in the musculoskeletal/orthopedics field.
They have demonstrated their great strengths and abilities, as shown
by SBi’s success in 2006, and I have every confidence that they
will embrace their new roles and promotions with the same level of
energy and drive in 2007.”
He added, “SBi hires, and looks to promote those who share the
same vision, mission and goals. Each of us as individuals, and the
Company as a whole, continually strive to be the global leader for
small bone & joint arthroplasty and reconstruction, serving small
bone & joint surgeons and their patients, worldwide.”
About Small Bone Innovations, Inc.
Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC,
(VB), the New York-based merchant banking firm that specializes in
the musculoskeletal /orthopedic sector. VB created SBi as the first
company to focus purely on small bone & joint science. By integrating established
companies and professionals in the field, SBi today offers a broad,
clinically proven portfolio of products and technologies to treat trauma
and diseases in small bones & joints.
In establishing SBi, VB acquired several prominent US, Canadian and
European orthopedic device companies and product technology licenses
focused on small bone and joint treatment, including arthroplasty,
& external fixation, trauma, and biologics.
SBi completed a Series B financing, raising a record total of $42.2
million, announced in January, 2006. Based on data provided by Venture
Source, this was the largest venture capital investment ever recorded
in the field of orthopedic devices
SBi was a 2006 recipient of Red Herring magazine's annual “'Red
Herring 100 North America" award, recognized as one of
the nation's leading technology companies and the only orthopedic
device company selected among an initial entry of more than one
thousand firms. Additionally, SBi's Artelon CMC-I Spacer, developed
for patients with thumb base osteoarthritis, was featured on the
cover and highlighted within Medical Design Technology magazine's “"Year
of Innovation" issue as one of the most fascinating technologies
influencing the medical device industry.
information on SBi, please visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB)
was the first venture capital/private equity and merchant banking firm
dedicated to the musculoskeletal/orthopedics sector of the health care
Today, VB is a leading independent firm with a mission to create, build
and finance companies founded on innovations developed by surgeons
and uniquely focused on "life changing" musculoskeletal/orthopedic
technologies. VB has worldwide surgeon, industry and trade relationships
and significant financial expertise in the musculoskeletal/orthopedic
As principals of VB, the Viscogliosi brothers have a combined total
of nearly half a century of experience analyzing and investing in
the musculoskeletal/orthopedics sector, directing literally billions
of dollars through the orthopedics industry. They have pioneered
innovative financial, strategic and management initiatives for nearly
150 companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead
better lives through the orthopedic and spinal products marketed
and sold by the companies they have assisted in developing and financing.
For more information about VB, please visit: www.vbllc.com
> Back to Press Releases